21 mai: US Stocks Advance As G-8 Comments Improve Sentiment On Euro Zone
21 mai: Cove Energy Continues To Believe Shell Offer In Shareholders&..
21/05/2012 17:10:00

Morgan Stanley Has A Number Of Facebook Orders That 'Remain Unexecuted' - Sources

Related content
Related debate
04 févr. - 
Har lukket positionen 76,1, regnskabet leverede ikke so..

By Brett Philbin

Of DOW JONES NEWSWIRES

NEW YORK -(Dow Jones)- Morgan Stanley (MS) has a number of Facebook Inc. (FB) orders submitted by financial advisers for its brokerage clients on Friday that "remain unexecuted," according to people familiar with the situation.

On Friday, Facebook's market debut was marred by trading glitches by the Nasdaq OMX Group Inc. (NDAQ), which delayed the start of trading in the social networking company by 30 minutes. In addition, many clients were left with orders that were processed improperly.

In the internal memo Monday, Morgan Stanley told advisers of its brokerage joint venture, Morgan Stanley Smith Barney, that the company expects to "be able to obtain and process execution for those trades today."

A Morgan Stanley spokeswoman declined to comment.

Shares of Facebook plunged on Monday, falling 12.3% to $33.53.

-By Brett Philbin, Dow Jones Newswires; 212-416-2173; brett.philbin@dowjones.com

(END) Dow Jones Newswires

May 21, 2012 11:10 ET (15:10 GMT)

Copyright (c) 2012 Dow Jones & Company, Inc.

21 mai: US Stocks Advance As G-8 Comments Improve Sentiment On Euro Zone
21 mai: Cove Energy Continues To Believe Shell Offer In Shareholders&..

Envoyer un commentaire

Related debate

  • 1 semaine
  • 1 mois
  • 1 an
Ingen indlæg

Annonces

Actualité la plus lue

  • 24 heures
  • 48 heures
  • 1 semaine
1
SYSTRAN : Défense et sécurité : Sinequa et SYSTRAN coopèrent dans l'analyse et le traitement multilingue du Big Data
2
Foncière Atland : Honoraires de commissariat aux comptes 2014.
3
PROLOGUE : Approbation du projet de rapprochement avec O2i par les actionnaires de Prologue
4
VRANKEN-POMMERY MONOPOLE - RESULTATS 2014 : RESULTAT OPERATIONNEL APRES OPERATION D'APPORT 49,5M€ (+51.4%) RESULTAT NET + 27,1 M€
5
AB Science : Le Comité Indépendant de Revue des Données recommande la poursuite de l'étude de phase 2 du masitinib dans le traitement du cancer de la tête et du cou

Related stock quotes

Facebook Inc- Class A 83,20 0,0% Cours de bourse inchangé
Morgan Stanley 36,31 0,0% Cours de bourse inchangé
The NASDAQ OMX Group Inc 50,70 0,0% Cours de bourse inchangé

Buy and sell signals

  • Tendance
  • Moneymachine

Related companies
Get access to information and recommendations of related companies with our PLUS package.

You get access to 7 valuable investment tools.

Click here to read more about the PLUS package.

Droit d'auteur Euroinvestor A/S 2015   Mentions légales et conditions d'utilisation
Information sur les cours fournies par Interactive Data.
Les données sont différées de 15 à 20 minutes selon les accords avec les différentes bourses internationales.
 
mardi 31 mars 2015 13:19:39
(UTC+01:00) Brussels, Copenhagen, Madrid, Paris
Version: LiveBranchBuild_20150325.1 - EUROWEB7 - 2015-03-31 13:19:39 - 2015-03-31 13:19:39 - 4 - Website: OKAY